The ins and outs of a polyglutamine neurodegenerative disease: Spinocerebellar ataxia type 1 (SCA1)

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations

Abstract

Polyglutamine neurodegenerative disorders are characterized by the expansion of a glutamine tract within the mutant disease-causing protein. Expression of the mutant protein induces a progressive loss of neuronal function and the subsequent neurodegeneration of a set of neurons characteristic to each disease. Spinocerebellar ataxia type 1 (SCA1) is one polyglutamine disease where various experimental model systems, in particular transgenic mice, have been utilized to dissect the molecular and cellular events important for disease. This review summarizes these findings and places them in a context of potential future research directions. (C) 2000 Academic Press.

Original languageEnglish (US)
Pages (from-to)129-134
Number of pages6
JournalNeurobiology of Disease
Volume7
Issue number3
DOIs
StatePublished - Jun 2000

Fingerprint Dive into the research topics of 'The ins and outs of a polyglutamine neurodegenerative disease: Spinocerebellar ataxia type 1 (SCA1)'. Together they form a unique fingerprint.

Cite this